Perinatal Substance Abuse

Miller, William H.; Hyatt, Mark C.

doi:10.3109/00952999209026065

Cited by 24 publications

(3 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Such problems are likely to affect not only caregiving abilities of the drug dependent woman, but also her ability to seek out and comply with much needed care for herself and her children. Chemically dependent mothers frequently experience difficulties maintaining trusting relationships, including those with medical and drug treatment care providers, leading to sporadic, inconsistent compliance and follow through with medical and social services-related appointments (Miller, 1992). Feelings of guilt surrounding relapse to drug use and fear of judgmental attitudes from clinical professionals often contribute to a drug abusing woman's reluctance to seek care in traditional medical institutions.…”

Section: Social Work In Mental Healthmentioning

confidence: 99%

Intensity of Case Management Services

Jansson

Svikis

Breon

et al. 2005

Social Work in Mental Health

View full text Add to dashboard Cite

Specialized programs for pregnant, drug dependent women have assisted many in achieving abstinence during pregnancy. Following delivery, however, such women often resume drug use and drop out of treatment, placing their children at even greater risk for subsequent medical and developmental problems. Standard outreach services, while generally effective as a public health measure for high-risk populations of women and children, are often insufficient for chronic and severely drug dependent women. The present study was a randomized clinical trial comparing maternal and infant outcomes for drug dependent women assigned to either routine or intensified case management services for the first 4 months following delivery. Women randomly assigned to intensified case management showed better treatment retention, accessed a greater variety of services, were more likely to L. M. Jansson, MD, is affiliated with Johns

show abstract

Section: Social Work In Mental Healthmentioning

confidence: 99%

Intensity of Case Management Services

Jansson

Svikis

Breon

et al. 2005

Social Work in Mental Health

View full text Add to dashboard Cite

show abstract

“…doi:10.1016/j.jsat.2004.07.004 practices among substance abusing women. Substance abusing mothers often have histories of poor parental role modeling, sexual, physical and emotional victimization, psychiatric co-morbidity, low self-esteem, high levels of stress, and feelings of guilt (Finnegan, 1994;Jansson & Velez, 1999;Miller & Hyatt, 1992), all of which may influence the way a woman approaches the task of child rearing. For example, although the long term consequences of in-utero drug exposure have not been completely established, the media and some clinical data continue to portray the in-utero drug exposed child as having suffered irreparable damage (Frank, Bresnahan, & Zuckerman, 1993;Myers, Olson, & Kaltenbach, 1992;Zuckerman, Frank, & Mayes, 2002).…”

Section: Introductionmentioning

confidence: 99%

Parenting knowledge among substance abusing women in treatment

Vélez

Jansson

Montoya

et al. 2004

Journal of Substance Abuse Treatment

View full text Add to dashboard Cite

“…They include medical record review, national self-report surveys, and retrospective analysis of administrative data from intervention research (8, 14-19). These may not provide adequate estimates among both genders.…”

mentioning

confidence: 99%

Refining Measurement of Substance Use Disorders Among Women of Child-Bearing Age Using Hospital Records: The Development of the Explicit-Mention Substance Abuse Need for Treatment in Women (EMSANT-W) Algorithm

Derrington

Bernstein

Belanoff

et al. 2015

Matern Child Health J

View full text Add to dashboard Cite

Substance use disorder (SUD) in women of reproductive age is associated with adverse health consequences for both women and their offspring. US states need a feasible population-based, case-identification tool to generate better approximations of SUD prevalence, treatment use, and treatment outcomes among women. This article presents the development of the Explicit Mention Substance Abuse Need for Treatment in Women (EMSANT-W), a gender-tailored tool based upon existing International Classification of Diseases, 9th Edition, Clinical Modification diagnostic code-based groupers that can be applied to hospital administrative data. Gender-tailoring entailed the addition of codes related to infants, pregnancy, and prescription drug abuse, as well as the creation of inclusion/exclusion rules based on other conditions present in the diagnostic record. Among 1,728,027 women and associated infants who accessed hospital care from January 1, 2002 to December 31, 2008 in Massachusetts, EMSANT-W identified 103,059 women with probable SUD. EMSANT-W identified 4,116 women who were not identified by the widely used Clinical Classifications Software for Mental Health and Substance Abuse (CCS-MHSA) and did not capture 853 women identified by CCS-MHSA. Content and approach innovations in EMSANT-W address potential limitations of the Clinical Classifications Software, and create a methodologically sound, gender-tailored and feasible population-based tool for identifying women of reproductive age in need of further evaluation for SUD treatment. Rapid changes in health care service infrastructure, delivery systems and policies require tools such as the EMSANT-W that provide more precise identification methods for sub-populations and can serve as the foundation for analyses of treatment use and outcomes.

show abstract

Perinatal Substance Abuse

Cited by 24 publications

References 34 publications

Intensity of Case Management Services

Intensity of Case Management Services

Parenting knowledge among substance abusing women in treatment

Refining Measurement of Substance Use Disorders Among Women of Child-Bearing Age Using Hospital Records: The Development of the Explicit-Mention Substance Abuse Need for Treatment in Women (EMSANT-W) Algorithm

Contact Info

Product

Resources

About